← Peptide Index

Growth hormone axis and recovery

CJC-1295 with DAC

The long-acting GHRH analog that keeps IGF-1 elevated.

CJC-1295 with DAC has human data showing sustained GH and IGF-1 increases. The open question is whether chronic elevation is actually what you want outside clinical research.

Evidence grade B
Anecdote grade B
Risk level Medium
Human data Moderate

Mechanism

What it probably does

CJC-1295 is a GHRH analog designed with a drug affinity complex that extends half-life and stimulates growth hormone release over days rather than minutes.

Claims vs data

Where people get carried away

The GH and IGF-1 signal is real. Claims about anti-aging and recomposition are much less settled.

Why people use it

  • IGF-1 increase
  • recovery
  • sleep quality
  • body composition experiments

What to track

  • IGF-1
  • fasting glucose
  • HbA1c
  • blood pressure
  • edema
  • sleep quality

In Short

CJC-1295 with DAC is not subtle. That is the appeal and the risk.

If IGF-1 climbs and glucose follows it, the peptide is not doing you a favor.

Kabal angle

If you experiment, make the data impossible to ignore.

Kabal is built for the part most peptide pages skip: tracking the outcome, the dose, the timing, and the biomarkers that tell you whether the story holds up.

Get Kabal for iOS